0001626971-15-000002.txt : 20150925 0001626971-15-000002.hdr.sgml : 20150925 20150925113605 ACCESSION NUMBER: 0001626971-15-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150925 DATE AS OF CHANGE: 20150925 EFFECTIVENESS DATE: 20150925 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Corvus Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001626971 IRS NUMBER: 464670809 STATE OF INCORPORATION: DE FISCAL YEAR END: 1214 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-248244 FILM NUMBER: 151124529 BUSINESS ADDRESS: STREET 1: 250 GOLDEN HILLS DRIVE CITY: PORTOLA VALLEY STATE: CA ZIP: 94028-7613 BUSINESS PHONE: 650 245 6535 MAIL ADDRESS: STREET 1: 250 GOLDEN HILLS DRIVE CITY: PORTOLA VALLEY STATE: CA ZIP: 94028-7613 D 1 primary_doc.xml X0707 D LIVE 0001626971 Corvus Pharmaceuticals, Inc. 863 MITTEN ROAD SUITE 102 BURLINGAME CA CALIFORNIA 94010 (650) 900-4520 DELAWARE None None Corporation true 2014 Richard A. Miller Corvus Pharmaceuticals, Inc. 863 Mitten Road, Suite 102 Burlingame CA CALIFORNIA 94010 Executive Officer Director Elisha (Terry) P. Gould Adams Street Partners, LLC One North Wacker Drive, Suite 2200 Chicago IL ILLINOIS 60606-2823 Director Leiv Lea Corvus Pharmaceuticals, Inc. 863 Mitten Road, Suite 102 Burlingame CA CALIFORNIA 94010 Executive Officer Peter Moldt Novo A/S Tuborg Havnevej 19 Kellenup G7 DENMARK 2900 Director Peter Thompson OrbiMed Advisors, LLC 601 Lexington Avenue, 54th Floor New York NY NEW YORK 10022-4629 Director Other Health Care Decline to Disclose 06b false 2015-09-16 false true true false 0 N/A None None None N/A N/A N/A XX Unknown 00000 CA CALIFORNIA IL ILLINOIS MD MARYLAND MA MASSACHUSETTS NY NEW YORK true 74999901 74999901 0 false 33 0 0 0 false Corvus Pharmaceuticals, Inc. /s/ Alan C. Mendelson Alan C. Mendelson Secretary 2015-09-24